CELLPOINT vs MCCHRLS-B: Stock Comparison
MAC CHARLES (INDIA) is the larger company by market capitalisation. MAC CHARLES (INDIA) shows a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
CELLPOINT leads 3; MCCHRLS-B leads 2 of 9
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Price
| Metric | CELLPOINT | MCCHRLS-B |
|---|---|---|
| Live Price | — | ₹655 |
| Day Change | — | -0.72% |
| Volume | — | 6,059 |
| 52-Week High | — | ₹799 |
| 52-Week Low | — | ₹580 |
| Distance from 52W High | — | -18.02% |
Valuation
| Metric | CELLPOINT | MCCHRLS-B |
|---|---|---|
| Market Cap | ₹27 Cr | ₹869 Cr |
| P/E Ratio | — | 0x |
| P/B Ratio | — | -84.89x |
| EPS | ₹0.03 | ₹-14.82 |
| Book Value | ₹39.77 | — |
| Dividend Yield | 0% | 0% |
Growth
| Metric | CELLPOINT | MCCHRLS-B |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | 107.94% | 0% |
| Qtr Profit Growth | -66.67% | -189.23% |
Profitability & Leverage
| Metric | CELLPOINT | MCCHRLS-B |
|---|---|---|
| ROE | 0.09% | — |
| ROCE | 0.34% | 1.02% |
| Net Margin | 0% | 0% |
| Operating Margin | 2.01% | 13.75% |
| Debt to Equity | 1.04x | — |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | CELLPOINT | MCCHRLS-B |
|---|---|---|
| Promoter Holding | 73.06% | 73.78% |
| FII Holding | 0% | — |
| DII Holding | 0% | 0.02% |
| Public Holding | 26.94% | 26.2% |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: CELLPOINT and MAC CHARLES (INDIA).
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.